Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.27% | 176.78 | 0.0% | $746.14m | |
| AMGN | Amgen, Inc. | 1.08% | 251.08 | 1.5% | $612.30m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.74% | 305.53 | 1.9% | $437.49m | |
| GILD | Gilead Sciences, Inc. | 5.16% | 66.21 | 1.0% | $435.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.32% | 643.29 | 2.6% | $372.05m | |
| ILMN | Illumina, Inc. | 8.77% | 226.59 | 3.3% | $330.40m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 5.74% | 4.42 | 0.7% | $308.97m | |
| NVAX | Novavax, Inc. | 2.00% | 42.30 | 75.7% | $284.25m | |
| BIIB | Biogen, Inc. | 0.63% | 222.38 | 1.8% | $205.32m | |
| BNTX | BioNTech SE | 1.33% | 162.48 | 0.0% | $158.03m | |
| GOVX | GeoVax Labs, Inc. | 1.59% | 2.55 | 0.0% | $140.51m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.97% | 96.94 | 4.2% | $104.96m | |
| CRSP | CRISPR Therapeutics AG | 1.88% | 80.14 | 0.6% | $104.75m | |
| PACB | Pacific Biosciences of California, Inc. | -4.89% | 8.36 | 6.2% | $98.27m | |
| MRTX | Mirati Therapeutics, Inc. | -0.06% | 86.32 | 1.6% | $96.84m |
Company Profile
Adagio Therapeutics, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.